Diabetes Care 44(10):24382444 Davies M, Faerch L, Jeppesen OK et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Tirzepatide acts on both GLP-1 and GIP receptors, and data suggests patients experience greater weight loss with it
The peptide may dissolve poorly when reconstituted, or the solution may appear cloudy rather than clear
Mohamed SK, Ahmed AAE, Elkhoely A (2023) Sertraline pre-treatment attenuates hemorrhagic transformation induced in rats after cerebral ischemia reperfusion via down regulation of neuronal CD163: Involvement of M1/M2 polarization interchange and inhibiting autophagy
Most patients see one to two pounds per week loss by week three or four of their first injection cycle